Assessment of Atrial Cardiomyopathy Using MRI as a Predictor of Cardiac Post-Operative Atrial Fibrillation After Cardiac Surgery.

NANot yet recruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Coronary Artery Bypass Grafting
Interventions
DEVICE

cardiac Magnetic Resonance Imaging (MRI)

Cardiac magnetic resonance imaging (MRI) will be realized before Coronary Artery Bypass Grafting for assess atrial cardiomyopathy.

BIOLOGICAL

Blood sample

Blood sample will be realized (4 tubes of 4ml blood, 16ml in total) before Coronary Artery Bypass Grafting.

PROCEDURE

Cardiac muscle biopsy

Cardiac muscle biopsy will be realized during Coronary Artery Bypass Grafting.

DEVICE

Holter-electrocardiogram (ECG)

Holter-electrocardiogram (ECG) will be realized 1 year after Coronary Artery Bypass Graftin during 3 days to diagnose the occurrence of atrial fibrillation.

OTHER

medical examination

medical examination will be realized 1 year after Coronary Artery Bypass Graftin. Theses datas will collected: events during the follow-up year and evaluation of the Holter-electrocardiogram result.

Trial Locations (1)

Unknown

CHU Saint-Etienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT04657835 - Assessment of Atrial Cardiomyopathy Using MRI as a Predictor of Cardiac Post-Operative Atrial Fibrillation After Cardiac Surgery. | Biotech Hunter | Biotech Hunter